Navigation Links
San Antonio Drug Side Effects Lawyer at Herrera Law Firm Says Blood Clot Research Raises Questions About Yaz, Yasmin and Ocella
Date:12/16/2012

San Antonio, TX (PRWEB) December 16, 2012

Yaz, Yasmin and Ocella injury lawyers today said a study published in the Canadian Medical Association Journal on Dec. 3 raises some alarming concerns about the birth control blood clot risk.

According to a Dec. 3, 2012, report in the Reuters about the study, women who have a hormone disorder known as polycystic ovary syndrome (PCOS) and who use birth control pills have twice the risk of blood clots than do other women who take the Pill.

A 2011 study also published in the Canadian Medical Association Journal linked the birth control pills Yaz, Yasmin and Ocella, which contain drospirenone, to a higher risk of blood clots, according to an article about the study reported in the Globe and Mail of Toronto on Nov. 7, 2011. The blood clot risk is about 3 or 4 in 1,000 for women who take drospirenone-containing birth control pills compared with 1 in 1,000 for women who take birth control pills without drospirenone, according to the Globe and Mail.

“The various studies linking blood clots to certain birth control pills are alarming,” said San Antonio dangerous drug lawyer Jorge Herrera, of The Herrera Law Firm, Inc. “We urge anyone who has experienced adverse birth control side effects such as blood clots or stroke to speak to an attorney about their rights.”

In study published on Nov. 11, 2011, researchers followed contraceptive use among 329,995 Israeli women over a nearly seven-year period. The women who took the drospirenone-containing birth control pills had a higher risk of blood clots, deep vein thrombosis and pulmonary embolism than women who took other types of birth control, according to the study.
Birth control pills with drospirenone are relatively new contraceptives. Older birth control pills do not contain drospirenone.

In earlier research, the Food and Drug Administration found that Yaz is linked to a blood clot risk that is higher than older types of birth control, according to a CBS News report in 2011. According to CBS, the study examined women who used Yaz between 2001 and 2007.

About The Herrera Law Firm, Inc.
Founded in 1983, The Herrera Law Firm, Inc. has successfully represented thousands of individuals and families who have been dealt catastrophic blows due to personal injuries from oil field accidents, car accidents, tractor-trailer truck accidents, construction accidents, workplace injuries, dangerous drugs and defective medical device injuries. Its mission is to rectify the wrongs committed against its clients so that they can regain their dignity, rebuild their lives, and reclaim financial stability.

The firm’s principal office is located at 111 Soledad St., Suite 1900, San Antonio, TX 78205. The local phone number is 210-224-1054, or call toll-free at 1-800-455-1054. Visit http://www.herreralaw.com for more information.

Read the full story at http://www.prweb.com/releases/birth-control-lawsuit/lawyers/prweb10211401.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Young girls more likely to report side effects after HPV vaccine
2. Preteens More Likely to Report HPV Vaccine Side Effects
3. Breast cancer patients suffer treatment-related side effects long after completing care
4. Breast Cancer Treatment Side Effects May Last for Years
5. Baldness Drug May Cause Sexual Side Effects: FDA
6. Study examines adverse effects among different radiation therapies for prostate cancer
7. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
8. Moffitt researcher publishes book on nutritional management of cancer treatment effects
9. Researchers see BPA effects in monkey mammary glands
10. Many Primary Care Docs Dont Know Long-Term Effects of Chemo: Survey
11. Dartmouth researchers investigate the cognitive effects of athlete head impacts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: